Utah Retirement Systems Regeneron Pharmaceuticals, Inc. Transaction History

Utah Retirement Systems

$8.7 Billion
Q3 2024

A detailed history of Utah Retirement Systems transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Utah Retirement Systems holds 17,292 shares of REGN stock, worth $11.5 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

17,292

Previous 17,228 0.37%

Holding current value

$11.5 Million

Previous $18.1 Million 0.39%

% of portfolio

0.21%

Previous 0.22%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $65,541 - $76,912	64 Added 0.37%	17,292 $18.2 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $465,446 - $564,517	-527 Reduced 2.97%	17,228 $18.1 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $12,637 - $13,906	-14 Reduced 0.08%	17,755 $17.1 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $47,285 - $53,783	-61 Reduced 0.34%	17,769 $15.6 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $29,082 - $35,463	42 Added 0.24%	17,830 $14.7 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $467,620 - $554,673	-668 Reduced 3.62%	17,788 $12.8 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $30,622 - $37,213	45 Added 0.24%	18,456 $15.2 Million
Q4 2022 Feb 15, 2023	SELL	$705.89 - $766.39 $123,530 - $134,118	-175 Reduced 0.94%	18,411 $13.3 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $52,231 - $65,913	91 Added 0.49%	18,586 $12.8 Million
Q2 2022 Aug 16, 2022	BUY	$548.35 - $738.84 $135,442 - $182,493	247 Added 1.35%	18,495 $10.9 Million
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $59,512 - $69,843	100 Added 0.55%	18,248 $12.7 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $22,282 - $27,509	41 Added 0.23%	18,148 $11.5 Million
Q3 2021 Nov 16, 2021	SELL	$574.03 - $680.96 $547,050 - $648,954	-953 Reduced 5.0%	18,107 $11 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $263,822 - $311,665	558 Added 3.02%	19,060 $10.6 Million
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $357,384 - $438,560	-800 Reduced 4.14%	18,502 $8.75 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $382,640 - $486,384	800 Added 4.32%	19,302 $9.33 Million
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $54,475 - $65,821	100 Added 0.54%	18,502 $10.4 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $1.41 Million - $1.84 Million	2,850 Added 18.33%	18,402 $11.5 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $27,345 - $31,839	100 Added 0.65%	15,552 $4.31 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $58,122 - $80,475	194 Added 1.27%	15,452 $4.84 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $180,086 - $212,751	484 Added 3.28%	15,258 $6.27 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $143,452 - $187,980	400 Added 2.78%	14,774 $5.55 Million
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $6.2 Million - $7.24 Million	14,374	14,374 $6.43 Million

Others Institutions Holding REGN

# of Institutions

1,486

Shares Held

83.9M

Call Options Held

1.29M

Put Options Held

1.47M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $71.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.

Account

Utah Retirement Systems Regeneron Pharmaceuticals, Inc. Transaction History